PainTEQ Announces Decision from Patent Trial and Appeal Board in IPR Proceeding
TAMPA, Fla., May 30, 2023 /PRNewswire/ — PainTEQ, a fast-growing medical innovation company, announced that on May 24, 2023, the Patent Trial and Appeal Board (PTAB) issued a final written decision in an inter partes review (IPR) proceeding directed to U.S. Patent No. 10,426,539 (539 Patent), handing PainTEQ a decisive victory. The patent is owned … Read more